Theravance Biopharma IncNASDAQ:TBPH
- LAST PRICE9.3400
- TODAY'S CHANGE (%)0.1400 (1.5217%)
- Bid / Lots8.8900/ 1
- Ask / Lots9.7800/ 1
- Open / Previous Close9.1300 / 9.2000
- Day Range
- 52 Week Range
- Volume433,019
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TBPH |
|---|---|---|
| 09:32 ET | 12782 | 9.13 |
| 09:34 ET | 100 | 9.13 |
| 09:36 ET | 100 | 9.13 |
| 09:38 ET | 1502 | 9.03 |
| 09:41 ET | 1001 | 9.05 |
| 09:45 ET | 1300 | 9.065 |
| 09:48 ET | 400 | 9.095 |
| 09:50 ET | 1300 | 9.21 |
| 09:52 ET | 100 | 9.2 |
| 09:54 ET | 200 | 9.21 |
| 09:56 ET | 100 | 9.23 |
| 09:57 ET | 1000 | 9.23 |
| 10:01 ET | 200 | 9.215 |
| 10:03 ET | 300 | 9.205 |
| 10:06 ET | 100 | 9.22 |
| 10:08 ET | 100 | 9.205 |
| 10:10 ET | 100 | 9.22 |
| 10:12 ET | 12289 | 9.28 |
| 10:14 ET | 100 | 9.25 |
| 10:17 ET | 100 | 9.25 |
| 10:19 ET | 800 | 9.23 |
| 10:21 ET | 900 | 9.21 |
| 10:24 ET | 1786 | 9.2 |
| 10:26 ET | 379 | 9.2 |
| 10:28 ET | 1805 | 9.22 |
| 10:32 ET | 392 | 9.23 |
| 10:35 ET | 100 | 9.2125 |
| 10:37 ET | 4111 | 9.2 |
| 10:39 ET | 10392 | 9.135 |
| 10:42 ET | 695 | 9.12 |
| 10:46 ET | 2272 | 9.11 |
| 10:48 ET | 3941 | 9.12 |
| 10:50 ET | 3671 | 9.14 |
| 10:51 ET | 200 | 9.15 |
| 10:53 ET | 100 | 9.165 |
| 10:55 ET | 2818 | 9.15 |
| 11:00 ET | 1838 | 9.16 |
| 11:02 ET | 1692 | 9.15 |
| 11:04 ET | 1410 | 9.15 |
| 11:06 ET | 200 | 9.155 |
| 11:08 ET | 400 | 9.15 |
| 11:09 ET | 300 | 9.155 |
| 11:11 ET | 6071 | 9.16 |
| 11:13 ET | 100 | 9.17 |
| 11:15 ET | 3675 | 9.12 |
| 11:18 ET | 300 | 9.12 |
| 11:20 ET | 2244 | 9.13 |
| 11:22 ET | 400 | 9.15 |
| 11:24 ET | 424 | 9.15 |
| 11:27 ET | 100 | 9.15 |
| 11:29 ET | 300 | 9.15 |
| 11:31 ET | 201 | 9.13 |
| 11:33 ET | 100 | 9.14 |
| 11:36 ET | 3317 | 9.12 |
| 11:38 ET | 3290 | 9.17 |
| 11:42 ET | 404 | 9.17 |
| 11:44 ET | 582 | 9.15 |
| 11:45 ET | 100 | 9.15 |
| 11:47 ET | 400 | 9.16 |
| 11:49 ET | 455 | 9.16 |
| 11:51 ET | 400 | 9.16 |
| 11:54 ET | 300 | 9.15 |
| 11:58 ET | 500 | 9.16 |
| 12:00 ET | 3200 | 9.2 |
| 12:03 ET | 950 | 9.21 |
| 12:05 ET | 100 | 9.19 |
| 12:07 ET | 3520 | 9.18 |
| 12:09 ET | 100 | 9.18 |
| 12:12 ET | 1069 | 9.15 |
| 12:14 ET | 500 | 9.13 |
| 12:16 ET | 300 | 9.13 |
| 12:20 ET | 701 | 9.1 |
| 12:21 ET | 7477 | 9.12 |
| 12:23 ET | 100 | 9.12 |
| 12:25 ET | 100 | 9.12 |
| 12:27 ET | 100 | 9.12 |
| 12:30 ET | 200 | 9.135 |
| 12:32 ET | 200 | 9.14 |
| 12:34 ET | 100 | 9.13 |
| 12:36 ET | 300 | 9.12 |
| 12:38 ET | 584 | 9.12 |
| 12:39 ET | 300 | 9.13 |
| 12:41 ET | 300 | 9.12 |
| 12:43 ET | 300 | 9.12 |
| 12:45 ET | 209 | 9.1307 |
| 12:48 ET | 200 | 9.14 |
| 12:50 ET | 2275 | 9.12 |
| 12:52 ET | 2480 | 9.12 |
| 12:54 ET | 4077 | 9.14 |
| 12:56 ET | 103 | 9.14 |
| 12:59 ET | 600 | 9.14 |
| 01:03 ET | 100 | 9.13 |
| 01:06 ET | 100 | 9.13 |
| 01:08 ET | 200 | 9.13 |
| 01:10 ET | 100 | 9.13 |
| 01:12 ET | 3301 | 9.18 |
| 01:14 ET | 200 | 9.16 |
| 01:15 ET | 1020 | 9.16 |
| 01:19 ET | 200 | 9.15 |
| 01:21 ET | 400 | 9.15 |
| 01:24 ET | 100 | 9.15 |
| 01:26 ET | 300 | 9.16 |
| 01:28 ET | 1013 | 9.17 |
| 01:30 ET | 600 | 9.17 |
| 01:32 ET | 710 | 9.16 |
| 01:35 ET | 815 | 9.16 |
| 01:39 ET | 100 | 9.15 |
| 01:42 ET | 100 | 9.15 |
| 01:46 ET | 791 | 9.15 |
| 01:48 ET | 1919 | 9.13 |
| 01:50 ET | 2506 | 9.14 |
| 01:51 ET | 200 | 9.13 |
| 01:53 ET | 200 | 9.13 |
| 01:55 ET | 1200 | 9.15 |
| 02:00 ET | 300 | 9.15 |
| 02:02 ET | 500 | 9.15 |
| 02:04 ET | 754 | 9.17 |
| 02:06 ET | 1303 | 9.155 |
| 02:08 ET | 447 | 9.15 |
| 02:11 ET | 400 | 9.13 |
| 02:13 ET | 300 | 9.15 |
| 02:15 ET | 100 | 9.13 |
| 02:18 ET | 1784 | 9.15 |
| 02:20 ET | 525 | 9.15 |
| 02:22 ET | 400 | 9.16 |
| 02:24 ET | 400 | 9.155 |
| 02:26 ET | 100 | 9.16 |
| 02:27 ET | 1691 | 9.13 |
| 02:29 ET | 427 | 9.12 |
| 02:31 ET | 2634 | 9.12 |
| 02:33 ET | 231 | 9.11 |
| 02:36 ET | 100 | 9.11 |
| 02:38 ET | 300 | 9.13 |
| 02:40 ET | 500 | 9.13 |
| 02:42 ET | 200 | 9.115 |
| 02:44 ET | 500 | 9.12 |
| 02:45 ET | 1126 | 9.105 |
| 02:47 ET | 200 | 9.11 |
| 02:49 ET | 100 | 9.1 |
| 02:51 ET | 3527 | 9.11 |
| 02:54 ET | 300 | 9.1 |
| 02:56 ET | 300 | 9.1 |
| 02:58 ET | 500 | 9.11 |
| 03:00 ET | 600 | 9.115 |
| 03:02 ET | 800 | 9.115 |
| 03:03 ET | 500 | 9.12 |
| 03:05 ET | 2651 | 9.11 |
| 03:07 ET | 1947 | 9.13 |
| 03:09 ET | 100 | 9.135 |
| 03:12 ET | 400 | 9.16 |
| 03:14 ET | 300 | 9.16 |
| 03:16 ET | 868 | 9.17 |
| 03:18 ET | 300 | 9.17 |
| 03:20 ET | 685 | 9.17 |
| 03:21 ET | 4205 | 9.16 |
| 03:23 ET | 210 | 9.15 |
| 03:25 ET | 400 | 9.16 |
| 03:27 ET | 200 | 9.17 |
| 03:30 ET | 4954 | 9.174 |
| 03:32 ET | 600 | 9.18 |
| 03:34 ET | 100 | 9.185 |
| 03:36 ET | 853 | 9.19 |
| 03:38 ET | 557 | 9.21 |
| 03:39 ET | 600 | 9.205 |
| 03:41 ET | 600 | 9.21 |
| 03:43 ET | 3500 | 9.24 |
| 03:45 ET | 1983 | 9.27 |
| 03:48 ET | 3924 | 9.25 |
| 03:50 ET | 7959 | 9.29 |
| 03:52 ET | 5546 | 9.33 |
| 03:54 ET | 700 | 9.35 |
| 03:56 ET | 7309 | 9.34 |
| 03:57 ET | 8991 | 9.335 |
| 03:59 ET | 107586 | 9.34 |
Apr 12, 2024
DJ Theravance Biopharma Initiated at Buy by BTIG, from 7:51AM ET on Friday Apr 12, 2024 by Dow Jones
7:51AM ET on Friday Apr 12, 2024 by Dow Jones
Apr 10, 2024
Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024, from 6:00AM ET on Wednesday Apr 10, 2024 by Dow Jones
6:00AM ET on Wednesday Apr 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Theravance Biopharma Inc | 446.8M | -9.6x | --- |
Aquestive Therapeutics Inc | 383.4M | -28.6x | --- |
Sanara Medtech Inc | 293.3M | -64.8x | --- |
Nektar Therapeutics | 242.4M | -0.9x | --- |
Precigen Inc | 328.6M | -3.4x | --- |
Jasper Therapeutics Inc | 349.6M | -3.5x | --- |
Company Information
Theravance Biopharma, Inc. is a biopharmaceutical company primarily focused on the development, and commercialization of medicines. Its product, YUPELRI (revefenacin) inhalation solution is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). YUPELRI is a prescription medicine used to treat COPD, a long-term lung disease that includes chronic bronchitis, emphysema, or both. YUPELRI is an anticholinergic medicine, which helps the muscles around the airway in lungs stay relaxed to prevent symptoms, such as wheezing, shortness of breath and others. Its pipeline of internally discovered programs is targeted to address unmet patient needs. Ampreloxetine, its late-stage investigational norepinephrine reuptake inhibitor in development for symptomatic neurogenic orthostatic hypotension. Its Selective 5-HT4 Agonist (TD-8954) is a selective 5-HT4 receptor agonist, which is developed for the treatment of gastrointestinal motility disorders.
Contact Information
- Headquarters
- UGLAND HOUSE, SOUTH CHURCH STREETGEORGE TOWN, Cayman Islands KY1-1104
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Rick Winningham
- Chief Financial Officer, Senior Vice President
- Aziz Sawaf
- Senior Vice President, General Counsel, Secretary
- Brett Grimaud
- Senior Vice President - Commercial and Medical Affairs, Chief Business Officer
- Rhonda Farnum
- Lead Independent Director
- Dean Mitchell
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $446.8M |
|---|---|
Revenue (TTM) | $57.4M |
Shares Outstanding | 48.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.34 |
EPS | $-0.97 |
Book Value | $4.43 |
P/E Ratio | -9.6x |
Price/Sales (TTM) | 7.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -97.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
